Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS was delisted on the 18th of July, 2023.
13 hedge funds and large institutions have $7.87M invested in Aridis Pharmaceuticals Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
27% more capital invested
Capital invested by funds: $6.22M → $7.87M (+$1.65M)
8% more funds holding
Funds holding: 12 → 13 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
+$316K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$224K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.3K |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$36.9K |
| 5 |
BlackRock
New York
|
+$32.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWM
Minot Wealth Management
Westwood,
Massachusetts
|
-$295K |
| 2 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
-$7.65K |
| 3 |
Morgan Stanley
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $3.33M | +$224K | +35,904 | +8% |
|
|
RAM
2
Roumell Asset Management
Chevy Chase,
Maryland
| $2.02M | +$316K | +50,664 | +23% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $1.18M | +$64.3K | +10,288 | +7% |
|
|
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
| $780K | – | – | – |
|
|
5
BlackRock
New York
| $234K | +$32.7K | +5,232 | +20% |
|
|
MWM
6
Minot Wealth Management
Westwood,
Massachusetts
| $152K | -$295K | -47,230 | -65% |
|
|
PCM
7
Perritt Capital Management
Chicago,
Illinois
| $118K | +$36.9K | +5,900 | +58% |
|
8
UBS Group
Zurich,
Switzerland
| $24K | +$20.2K | +3,229 | New |
|
9
Wells Fargo
San Francisco,
California
| $9K | +$31 | +5 | +0.4% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $8K | +$6.57K | +1,052 | New |
|
11
Citigroup
New York
| $6K | – | – | – |
|
|
NFSG
12
Newbridge Financial Services Group
Boca Raton,
Florida
| $3K | +$2.5K | +400 | New |
|
|
FP
13
Financial Perspectives
Minneapolis,
Minnesota
| $1.85K | -$7.65K | -1,225 | -83% |
|
|
14
Morgan Stanley
New York
| – | -$3K | -500 | Closed |
|
ARDS Hedge Fund Activity: Q2 2021 in Review
13 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) for Q2 2021, worth a combined $7.87M — up 27% from $6.22M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ARDS positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Roumell Asset Management, adding an estimated $316K. The largest seller was Minot Wealth Management, cutting an estimated $295K.
- 13 institutional investors held Aridis Pharmaceuticals Inc. Common Stock (ARDS) as of Q2 2021, up from 12 in Q1 2021.
- Funds reported $7.87M of Aridis Pharmaceuticals Inc. Common Stock stock for Q2 2021, up 27% quarter-over-quarter.
- 3 funds opened new Aridis Pharmaceuticals Inc. Common Stock positions in Q2 2021 and 2 closed out, a net change of +1 holder.
- The largest Aridis Pharmaceuticals Inc. Common Stock buyer in Q2 2021 was Roumell Asset Management, an estimated $316K added.
- The largest Aridis Pharmaceuticals Inc. Common Stock seller in Q2 2021 was Minot Wealth Management, an estimated $295K sold.
Based on aggregated 13F filings for Q2 2021.